SearchCatalogResearchTools
Research & Educational Use Only. This guide describes the published FDA-approved Wegovy/Ozempic titration schedule for research reference. It is not medical advice, is not a recommendation for personal use, and is not intended for human consumption outside of physician-directed therapy.

FDA Boxed Warning — Risk of Thyroid C-Cell Tumors

Semaglutide causes thyroid C-cell tumors in rodents. It is unknown whether it causes medullary thyroid carcinoma (MTC) in humans. Contraindicated in anyone with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Other labeled risks: pancreatitis, gallbladder disease, acute kidney injury, diabetic retinopathy complications, hypoglycemia when combined with insulin/sulfonylureas, hypersensitivity reactions. Discontinue at least 2 months before a planned pregnancy (long washout). See the full FDA label on DailyMed.

Compounding status (updated 2026-04-23): FDA declared the semaglutide shortage resolved February 21, 2025. 503A pharmacies ceased compounding April 22, 2025; 503B facilities ceased May 22, 2025. Compounded semaglutide is now restricted to narrow patient-specific clinical-difference exemptions.
GLP-1 Receptor Agonist Weekly Protocol Guide

Semaglutide Protocol Guide

✓ Verified dosing (fact-checked against FDA labels / published trials): Once-weekly subcutaneous. Weight management (Wegovy regimen): titrate 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly, +1 step every 4 weeks. Type 2 diabetes (Ozempic) maxes at 2 mg weekly. Prescription drug — requires a licensed provider. This supersedes any conflicting figures shown elsewhere on this page; confirm with a licensed provider.

Semaglutide is a GLP-1 receptor agonist studied for metabolic research. It mimics incretin hormone GLP-1 released after eating, influencing glucose regulation and appetite signaling.

Protocol Overview

Compound
Semaglutide (Research Peptide for Metabolic Studies)
Category
GLP-1 Receptor Agonist
Vial Size
5mg (5,000mcg)
Reconstitution
2mL bacteriostatic water (2.5mg/mL)
Route
Subcutaneous injection
Frequency
Once weekly

Reconstitution Instructions

Using 2mL of bacteriostatic water results in a concentration of 2.5mg/mL. Start low and titrate up. Always use sterile techniques.

Materials Needed

  • Semaglutide 5mg vial (lyophilized powder)
  • 2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
  • Sterile syringe and needle (18-22 gauge for drawing)
  • Alcohol swabs
  • Clean workspace

Step-by-Step Process

  1. Preparation: Allow the Semaglutide 5mg vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
  2. Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles.
  3. Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
  4. Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
  5. Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.

Weekly Dosing Schedule (Titration Protocol)

Semaglutide requires a gradual dose escalation to minimize GI side effects. Increase every 4 weeks as tolerated.

WeeksDoseUnits (at 2.5mg/mL)Frequency
Weeks 1–40.25mg (250mcg)10 units (0.1mL)Once weekly
Weeks 5–80.5mg (500mcg)20 units (0.2mL)Once weekly
Weeks 9–121mg (1,000mcg)40 units (0.4mL)Once weekly
Weeks 13–161.7mg (1,700mcg)68 units (0.68mL)Once weekly
Weeks 17+2.4mg (2,400mcg) max96 units (0.96mL)Once weekly

Starting dose: 0.25mg once weekly • Max dose: 2.4mg once weekly • Vial Duration: ~5 weeks at 0.25mg or ~2 doses at 2.4mg (5mg vial)

Quick Dosing Reference (at 2.5mg/mL)

Units (Ticks)Dose (mcg)Dose (mg)
102500.25mg
205000.5mg
401,0001mg
681,7001.7mg
962,4002.4mg

Administration Guidelines

  • Administer subcutaneously once weekly on the same day each week
  • Rotate injection sites between abdomen, thigh, and upper arm
  • Start at lowest dose and titrate up every 4 weeks
  • Store reconstituted peptide refrigerated at 36-46F (2-8C)
  • Use reconstituted solution within 30 days
  • Never freeze reconstituted peptides
  • Document administration times and observations

Storage Requirements

StateStorage Conditions
Lyophilized (powder)Room temperature or refrigerated, protect from light
ReconstitutedRefrigerated 36-46F (2-8C), use within 30 days

Frequently Asked Questions

What is the standard Semaglutide dosing protocol?
How do you reconstitute Semaglutide?
What are the storage requirements for Semaglutide?
How do you reconstitute Semaglutide?
What are the storage requirements for Semaglutide?

Lyophilized (powder): Room temperature or refrigerated, protect from light. Reconstituted: Refrigerated 36-46F (2-8C), use within 30 days.

Frequently Asked Questions

What is the standard Semaglutide dosing protocol?

See the fact-checked Verified Dosing shown at the top of this page (verified against the FDA label / published trials); always confirm with a licensed provider.

How do you reconstitute Semaglutide?

Add 2mL of bacteriostatic water to a 5mg vial for a concentration of 2.5mg/mL. Start at the lowest dose and titrate up every 4 weeks.

What are the storage requirements for Semaglutide?

Lyophilized (powder): Room temperature or refrigerated, protect from light. Reconstituted: Refrigerated 36-46F (2-8C), use within 30 days.

⚠ Before any use: human safety data is limited or absent for many of these compounds. Consult a licensed healthcare provider first — especially if you are pregnant or nursing, have a medical condition, or take other medications.